Annual Book Value
$33.26 M
-$40.26 M-54.76%
December 31, 2023
Summary
- As of February 10, 2025, CALT annual book value is $33.26 million, with the most recent change of -$40.26 million (-54.76%) on December 31, 2023.
- During the last 3 years, CALT annual book value has fallen by -$114.57 million (-77.50%).
Performance
CALT Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Book Value
$10.06 M
-$1.22 M-10.79%
June 30, 2024
Summary
- As of February 10, 2025, CALT quarterly book value is $10.06 million, with the most recent change of -$1.22 million (-10.79%) on June 30, 2024.
- Over the past year, CALT quarterly book value has dropped by -$1.22 million (-10.79%).
Performance
CALT Quarterly Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Book Value Formula
Book Value = Total Assets − Total Liabilities
CALT Book Value Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -54.8% | -10.8% |
| 3 y3 years | -77.5% | -89.3% |
| 5 y5 years | -51.7% | -85.8% |
CALT Book Value Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -70.2% | at low | -91.0% | at low |
| 5 y | 5-year | -77.5% | at low | -93.4% | at low |
| alltime | all time | -77.5% | -104.7% | -93.4% | -91.9% |
Calliditas Therapeutics AB (Publ) Book Value History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $10.06 M(-10.8%) |
| Mar 2024 | - | $11.28 M(-66.1%) |
| Dec 2023 | $33.26 M(-54.8%) | $33.26 M(+3.0%) |
| Sep 2023 | - | $32.29 M(-30.5%) |
| Jun 2023 | - | $46.45 M(-36.8%) |
| Dec 2022 | $73.52 M(-34.0%) | $73.52 M(+12.8%) |
| Sep 2022 | - | $65.18 M(-7.6%) |
| Jun 2022 | - | $70.57 M(-25.2%) |
| Mar 2022 | - | $94.32 M(-15.4%) |
| Dec 2021 | $111.45 M(-24.6%) | $111.45 M(-22.3%) |
| Sep 2021 | - | $143.50 M(+30.3%) |
| Jun 2021 | - | $110.10 M(-12.4%) |
| Mar 2021 | - | $125.64 M(-15.0%) |
| Dec 2020 | $147.82 M | $147.82 M(-3.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $153.56 M(+0.5%) |
| Jun 2020 | - | $152.86 M(+111.5%) |
| Mar 2020 | - | $72.26 M(-14.3%) |
| Dec 2019 | $84.33 M(+22.5%) | $84.33 M(+1.9%) |
| Sep 2019 | - | $82.80 M(+16.4%) |
| Jun 2019 | - | $71.11 M(+14.8%) |
| Mar 2019 | - | $61.93 M(-10.0%) |
| Dec 2018 | $68.84 M(+1596.8%) | $68.84 M(-7.3%) |
| Sep 2018 | - | $74.23 M(+9043.4%) |
| Jun 2018 | - | $811.80 K(-72.9%) |
| Mar 2018 | - | $2.99 M(-26.3%) |
| Dec 2017 | $4.06 M(-358.6%) | $4.06 M |
| Dec 2016 | -$1.57 M(-172.9%) | - |
| Dec 2015 | $2.15 M | - |
FAQ
- What is Calliditas Therapeutics AB (publ) annual book value?
- What is the all time high annual book value for Calliditas Therapeutics AB (publ)?
- What is Calliditas Therapeutics AB (publ) annual book value year-on-year change?
- What is Calliditas Therapeutics AB (publ) quarterly book value?
- What is the all time high quarterly book value for Calliditas Therapeutics AB (publ)?
- What is Calliditas Therapeutics AB (publ) quarterly book value year-on-year change?
What is Calliditas Therapeutics AB (publ) annual book value?
The current annual book value of CALT is $33.26 M
What is the all time high annual book value for Calliditas Therapeutics AB (publ)?
Calliditas Therapeutics AB (publ) all-time high annual book value is $147.82 M
What is Calliditas Therapeutics AB (publ) annual book value year-on-year change?
Over the past year, CALT annual book value has changed by -$40.26 M (-54.76%)
What is Calliditas Therapeutics AB (publ) quarterly book value?
The current quarterly book value of CALT is $10.06 M
What is the all time high quarterly book value for Calliditas Therapeutics AB (publ)?
Calliditas Therapeutics AB (publ) all-time high quarterly book value is $153.56 M
What is Calliditas Therapeutics AB (publ) quarterly book value year-on-year change?
Over the past year, CALT quarterly book value has changed by -$1.22 M (-10.79%)